<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_July_26 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/July/26</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Tuesday_26th_July"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Tuesday 26<SUP>th</SUP> July</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Visualization"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#High_fidelity_PCR_on_bacteria_transformed_with_pPS16_001.2C_pPS16_003.2C_pPS16_005_and_pPS16_009"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">High fidelity PCR on bacteria transformed with pPS16_001, pPS16_003, pPS16_005 and pPS16_009</SPAN></A></LI><LI class="toclevel-3 tocsection-4"><A href="#Low_Fidelity_Dreamtaq_PCR_of_DH5.CE.B1.7CpPS16_002"><SPAN class="tocnumber">1.1.2</SPAN><SPAN class="toctext">Low Fidelity Dreamtaq PCR of DH5α|pPS16_002</SPAN></A></LI><LI class="toclevel-3 tocsection-5"><A href="#gBlock_1.1.2C_3.1_and_GFP1-9_insertion_in_puc19"><SPAN class="tocnumber">1.1.3</SPAN><SPAN class="toctext">gBlock 1.1, 3.1 and GFP1-9 insertion in puc19</SPAN></A></LI></UL><LI class="toclevel-2 tocsection-6"><A href="#Biobrick_Characterization"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">Biobrick Characterization</SPAN></A></LI><LI class="toclevel-3 tocsection-7"><A href="#BL21_electrocompetent_cells_preparation_and_transformation"><SPAN class="tocnumber">1.2.1</SPAN><SPAN class="toctext">BL21 electrocompetent cells preparation and transformation</SPAN></A></LI><LI class="toclevel-3 tocsection-8"><A href="#Culture_of_BL21_electrocompetent_cells"><SPAN class="tocnumber">1.2.2</SPAN><SPAN class="toctext">Culture of BL21 electrocompetent cells</SPAN></A></LI></DIV><H1><SPAN class="mw-headline" id="Tuesday_26th_July">Tuesday 26<SUP>th</SUP> July</SPAN></H1><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="High_fidelity_PCR_on_bacteria_transformed_with_pPS16_001.2C_pPS16_003.2C_pPS16_005_and_pPS16_009">High fidelity PCR on bacteria transformed with <A href="/Team:Paris_Saclay/Notebook/June/28#pPS16_001" title="Team:Paris Saclay/Notebook/June/28">pPS16_001</A>, <A href="/Team:Paris_Saclay/Notebook/June/28#pPS16_003" title="Team:Paris Saclay/Notebook/June/28">pPS16_003</A>, <A href="/Team:Paris_Saclay/Notebook/June/28#pPS16_005" title="Team:Paris Saclay/Notebook/June/28">pPS16_005</A> and <A href="/Team:Paris_Saclay/Notebook/June/28#pPS16_009" title="Team:Paris Saclay/Notebook/June/28">pPS16_009</A></SPAN></H4><P><I>By Alice</I></P><P>PCR peformed on <A href="/Team:Paris_Saclay/Notebook/July/25#PCR_1.1_3.1_GFP" title="Team:Paris Saclay/Notebook/July/25">July 25</A> with bacteria containing plasmids pPS16_001, pPS16_005 and pPS16_009 did not give us expected results. We performed again this PCR, adding bacteria transformed with pPS16_003 (clone 3) that got good sequencing results. The PCR with Q5® High-Fidelity 2X Master Mix was performed on these clones following <A href="/Team:Paris_Saclay/Experiments#Q5PCR" title="Team:Paris Saclay/Experiments">this protocol</A>. Specific <A href="/Team:Paris_Saclay/Experiments#primers" title="Team:Paris Saclay/Experiments">primers</A> were used for each plasmids (table below). Annealing temperature calculated was 72°C. After amplification, 1 µL of loading dye was added to 5µL of each PCR products. Then 5 µL of this mix were put on gel. PCR products were migrated 25min at 100V.
</P><P>PCR products expected were :
</P><TABLE class="wikitable"><TBODY><TR><TH>Plasmids
</TH><TH>gBlocks
</TH><TH>Primer Forward
</TH><TH>Primer Reverse
</TH><TH>Band size (bp)
</TH></TR><TR><TD>pPS16_001
</TD><TD>1.1
</TD><TD>iPS138
</TD><TD>iPS120
</TD><TD>960
</TD></TR><TR><TD>pPS16_003
</TD><TD>2.1
</TD><TD>iPS123
</TD><TD>iPS124
</TD><TD>1023
</TD></TR><TR><TD>pPS16_005
</TD><TD>3.1
</TD><TD>iPS138
</TD><TD>iPS126
</TD><TD>960
</TD></TR><TR><TD>pPS16_009
</TD><TD>GFP 1-9
</TD><TD>iPS138
</TD><TD>iPS139
</TD><TD>862
</TD></TR></TBODY></TABLE><DIV class="thumb tright"><DIV class="thumbinner" style="width:373px;"><DIV class="thumbcaption">Results of PCR products (Gblocks 1.1, 2.1, 3.1, GFP) electrophoresis</DIV></DIV></DIV><H4><SPAN class="mw-headline" id="Low_Fidelity_Dreamtaq_PCR_of_DH5.CE.B1.7CpPS16_002">Low Fidelity Dreamtaq PCR of DH5α|pPS16_002</SPAN></H4><P><I>By Laetitia</I></P><P>We made a DreamTaq PCR on DH5α|pPS16_002 transformed cultures containing the Gblock 1.2.
</P><P>The PCR was done on 6 clones of transformed cells: 4 clones of the Petri dish from 19/07 and 2 clones of the Petri dish from 22/07.
The usual <A href="/Team:Paris_Saclay/Experiments#Polymerase_chain_reaction" title="Team:Paris Saclay/Experiments">protocol</A> was used with TM at 57°C.
</P><P>These 6 clones were spread on a Petri dish containing LB, Ampicilin, IPTG and X-Gal.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:395px;"><DIV class="thumbcaption">Results of PCR products (Gblocks 1.2) electrophoresis</DIV></DIV></DIV><H4><SPAN class="mw-headline" id="gBlock_1.1.2C_3.1_and_GFP1-9_insertion_in_puc19">gBlock 1.1, 3.1 and GFP1-9 insertion in puc19</SPAN></H4><P><I>By Caroline</I></P><P>The gblocks were inserted once again in puc19 this time after HincII were desactivated after puc19 digestion. Indeed, we noticed that those gBlocks contain a hincII restriction sites which explain why we did not obtain PCR amplification with the specific <A href="/Team:Paris_Saclay/Experiments#primers" title="Team:Paris Saclay/Experiments">primers</A>.
To carry out this insertion, the usual <A href="/Team:Paris_Saclay/Experiments#Ligation" title="Team:Paris Saclay/Experiments">protocol</A> was made.
</P><H3><SPAN class="mw-headline" id="Biobrick_Characterization">Biobrick Characterization</SPAN></H3><H4><SPAN class="mw-headline" id="BL21_electrocompetent_cells_preparation_and_transformation">BL21 electrocompetent cells preparation and transformation</SPAN></H4><P><I>By Léa, Charlène and Sylvie</I></P><P>We did an <A href="/Team:Paris_Saclay/Experiments#ElectroCompetent" title="Team:Paris Saclay/Experiments">electrotransformation</A> of BL21 with two different solutions of glycerol because we suspected that our solution where the root of our problem of transformation.
</P><P>As we have problem with this electrotransformation, the transformation was made twice this time: once by us and another by the I2BC staff.
</P><P>iGEM team's glycerol :
</P><UL><LI> pcl_TAA + K1372001 (time constant equal to 5.8ms)</LI><LI> pcl_TAG + K1372001 (time constant equal to 6,2 ms)</LI><LI> pcl_Tq + K1372001 (time constant equal to 6 ms)</LI><LI>K1372001 (time constant equal to 6 ms)</LI></UL><P>Sylvie team's glycerol:
</P><UL><LI> pcl_TAA + K1372001 (time constant equal to 6 ms)</LI><LI> pcl_TAG + K1372001 (time constant equal to 6 ms)</LI></UL><P>For the third conditions with iGEM team's glycerol, cells were spread on LB + Streptomycin (50µg/mL) + Chloramphenicol (30µg/mL) medium. For each condition, we made a Petri dish with 50µL of cells and another with 500µL of cells. 150µL of BL21|K1372001 were spread on LB + Chloramphenicol medium.
</P><P>For BL21 transformed with Sylvie team's glycerol, 150µL were spread on LB + Streptomycin + Chloramphenicol medium.
</P><P>Two controls were made with 100µL of BL21 which were spread on LB + Chloramphénicol or LB + Streptomycin medium.
</P><P>Cells grew overnight at 37°C.
</P><H4><SPAN class="mw-headline" id="Culture_of_BL21_electrocompetent_cells">Culture of BL21 electrocompetent cells</SPAN></H4><P><I>By Léa</I></P><P>A BL21 colony was put into 4mL of liquid LB medium, and grown at 37°C, 180 rpm overnight.
</P></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>